BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29710674)

  • 1. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.
    Fellenberg J; Sähr H; Kunz P; Zhao Z; Liu L; Tichy D; Herr I
    Cancer Lett; 2016 Feb; 371(1):134-41. PubMed ID: 26655997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
    He Q; Xue S; Tan Y; Zhang L; Shao Q; Xing L; Li Y; Xiang T; Luo X; Ren G
    Cancer Lett; 2019 Apr; 448():94-104. PubMed ID: 30742942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
    Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab Induces Neoplastic Stromal Cell Apoptosis
    Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
    Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
    Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
    Jin Y; Zhang J; Zhu H; Fan G; Zhou G
    Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
    PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway.
    Zhu B; Chen H; Zhang X; Pan Y; Jing R; Shen L; Wang X; Ju S; Jin C; Cong H
    Int J Oncol; 2018 Nov; 53(5):2131-2144. PubMed ID: 30132507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
    Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
    Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
    Peng C; Li Z; Niu Z; Niu W; Xu Z; Gao H; Niu W; Wang J; He Z; Gao C; Lin P; Agrez M; Zhang Z; Niu J
    Sci Rep; 2016 Feb; 6():20500. PubMed ID: 26846153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells.
    Wang F
    J Int Med Res; 2019 Feb; 47(2):926-935. PubMed ID: 30614349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.